ATI RN Pharmacology 2019 II | Nurselytic

Questions 60

ATI RN

ATI RN Test Bank

ATI RN Pharmacology 2019 II Questions

Extract:


Question 1 of 5

A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?

Correct Answer: C

Rationale: The correct answer is C. The nurse should file an incident report because the client had chemotherapy 12 hours before the filgrastim was administered. This timing is crucial as filgrastim is typically given to boost neutrophil production after chemotherapy to prevent infections. Administering filgrastim too soon after chemotherapy may not be effective and could potentially harm the client. Option A is not a reason to file an incident report as flushing the IV line with dextrose 5% in water is a standard practice. Option B, the client's neutrophil count, is not a reason for an incident report as it is a baseline assessment. Option D, the temperature of the medication vial, is also not a reason for an incident report unless it specifically affected the medication's stability.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days